home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Electronic Health Records to Electronic Data Capture: Enhancing the Data Journey in Oncology Clinical Trials

 
  April 12, 2024  
     
 
Xtalks, Online
2024-05-02


The choices made in clinical trial setup — from patient recruitment strategies to data collection methods — directly impact the success and cost of a trial. Efficiency and data quality are crucial at every point in the drug development process.

The drug development industry has moved from paper-based data collection methods to the use of electronic data capture (EDC) systems over the past two decades. Subsequently, healthcare providers have moved to electronic health records (EHRs). There is significant value in linking these two technologies, and it is predicted that within five years, an EHR-to-EDC system will be a tool most research centers — even smaller trial sites — leverage to streamline and optimize their trial processes.

While EHRs and EDC systems are digital, the connection between them mainly is not digital but analog. This non-digital connection creates an opportunity for innovative approaches using technology to streamline trial processes better, enhancing data accuracy, reducing cost and expediting the development of new therapies. This directly benefits patient safety, trial accessibility, patient engagement and patient recruitment.

Register for this webinar to learn how to avoid any stumbles and how to prepare for and integrate EHR to EDC into your oncology clinical trial operations.

Keywords: Clinical Data, HER Integration, Sites, EHRs, EHR, Therapeutic Areas, Oncology Clinical Trials, EDC, Oncology Trials, Clinical Trials, Electronic Data Capture (EDC), Oncology, Electronic Health Records, CRO, Clinical Research, Drug Development, Cancer
 
 
Organized by: Xtalks
Invited Speakers: Anthony W. Tolcher, MD, FRCPC, FACP, FASCO, Director of Clinical Research, Founder and CEO of NEXT Oncology
Andrew Zupnick, PhD, Vice President, Oncology Drug Development, Catalyst Oncology
Craig McIlloney, Senior Vice President, Catalyst Flex
Jackie Kent, Executive Industry Advisor
 
Deadline for Abstracts: 2024-05-02
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.